{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:56:46Z","timestamp":1794437806539,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is a common endocrine disorder among reproductive-age women. The mechanism by which circular RNA (circRNA) drives PCOS development remains unclear. Thus, the study is designed to explore the role of a novel circRNA, circ_FURIN, in the PCOS cell model and the underlying mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PCOS cell model was established by treating human ovarian granulosa-like tumor cells (KGN) with Testosterone (TTR). RNA expressions of circ_FURIN, microRNA-423-5p (miR-423-5p) and myotubularin 1 (MTM1) were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Protein expression was checked by Western blot. Cell proliferation was investigated by a 5-Ethynyl-29-deoxyuridine assay, 3-(4,5-Dimethylthazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry analysis for cell cycle. Apoptotic cells were quantified by flow cytometry analysis for cell apoptosis. The interplay between miR-423-5p and circ_FURIN or MTM1 was identified by dual-luciferase reporter and RNA pull-down assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Circ_FURIN and MTM1 expressions were significantly upregulated, whereas miR-423-5p was downregulated in the ovarian cortex tissues of PCOS patients and TTR-treated KGN cells compared with controls. Circ_FURIN depletion relieved TTR-induced proliferation inhibition and apoptosis promotion. Besides, knockdown of miR-423-5p, a target miRNA of circ_FURIN, rescued circ_FURIN knockdown-mediated effects under TTR treatment. MiR-423-5p remitted TTR-induced cell disorders by binding to MTM1. Moreover, circ_FURIN modulated MTM1 expression through miR-423-5p.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Circ_FURIN silencing protected against TTR-induced dysfunction by the miR-423-5p\/MTM1 pathway in human ovarian granulosa-like tumor cells.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-022-00891-9","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T07:02:58Z","timestamp":1645081378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Circ_FURIN knockdown assuages Testosterone-induced human ovarian granulosa-like tumor cell disorders by sponging miR-423-5p to reduce MTM1 expression in polycystic ovary syndrome"],"prefix":"10.1186","volume":"20","author":[{"given":"Xia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaibing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"891_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3945\/ajcn.2010.29261","volume":"92","author":"KA Marsh","year":"2010","unstructured":"Marsh KA, Steinbeck KS, Atkinson FS, Petocz P, Brand-Miller JC. Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome. Am J Clin Nutr. 2010;92:83\u201392. https:\/\/doi.org\/10.3945\/ajcn.2010.29261.","journal-title":"Am J Clin Nutr"},{"key":"891_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/des463","volume":"28","author":"NK Stepto","year":"2013","unstructured":"Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Human reproduction (Oxford, England). 2013;28:777\u201384. https:\/\/doi.org\/10.1093\/humrep\/des463.","journal-title":"Human reproduction (Oxford, England)"},{"key":"891_CR3","first-page":"27","volume":"70","author":"C FuxOtta","year":"2013","unstructured":"FuxOtta C, Fiol de Cuneo M, Szafryk de Mereshian P. Polycystic ovary syndrome: physiopathology review. Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina). 2013;70:27\u201330.","journal-title":"Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)"},{"key":"891_CR4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1095\/biolreprod.109.082941","volume":"82","author":"RJ Rodgers","year":"2010","unstructured":"Rodgers RJ, Irving-Rodgers HF. Formation of the ovarian follicular antrum and follicular fluid. Biol Reprod. 2010;82:1021\u20139. https:\/\/doi.org\/10.1095\/biolreprod.109.082941.","journal-title":"Biol Reprod"},{"key":"891_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333\u20138. https:\/\/doi.org\/10.1038\/nature11928.","journal-title":"Nature"},{"key":"891_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141214","volume":"10","author":"S Memczak","year":"2015","unstructured":"Memczak S, Papavasileiou P, Peters O, Rajewsky N. Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood. PLoS ONE. 2015;10: e0141214. https:\/\/doi.org\/10.1371\/journal.pone.0141214.","journal-title":"PLoS ONE"},{"key":"891_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391. https:\/\/doi.org\/10.1038\/s41576-019-0158-7.","journal-title":"Nat Rev Genet"},{"key":"891_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","volume":"187","author":"B Han","year":"2018","unstructured":"Han B, Chao J, Yao H. Circular RNA and its mechanisms in disease: From the bench to the clinic. Pharmacol Ther. 2018;187:31\u201344. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.01.010.","journal-title":"Pharmacol Ther"},{"key":"891_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.fertnstert.2019.02.023","volume":"111","author":"Q Che","year":"2019","unstructured":"Che Q, Liu M, Xu J, Liu Y, Cao X, Dong X, Liu S. Characterization of circular RNA expression profiles in cumulus cells from patients with polycystic ovary syndrome. Fertil Steril. 2019;111:1243-1251.e1241. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.02.023.","journal-title":"Fertil Steril"},{"key":"891_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/genes5030684","volume":"5","author":"AE S\u00f8rensen","year":"2014","unstructured":"S\u00f8rensen AE, Wissing ML, Sal\u00f6 S, Englund AL, Dalgaard LT. MicroRNAs Related to Polycystic Ovary Syndrome (PCOS). Genes. 2014;5:684\u2013708. https:\/\/doi.org\/10.3390\/genes5030684.","journal-title":"Genes"},{"key":"891_CR11","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141:1202\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.034.","journal-title":"J Allergy Clin Immunol"},{"key":"891_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1089\/dna.2019.4622","volume":"38","author":"Z Chen","year":"2019","unstructured":"Chen Z, Ou H, Wu H, Wu P, Mo Z. Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome. DNA Cell Biol. 2019;38:754\u201362. https:\/\/doi.org\/10.1089\/dna.2019.4622.","journal-title":"DNA Cell Biol"},{"key":"891_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/1759-7714.13745","volume":"12","author":"Y Huang","year":"2021","unstructured":"Huang Y, Feng G. MiR-423-5p aggravates lung adenocarcinoma via targeting CADM1. Thoracic cancer. 2021;12:210\u20137. https:\/\/doi.org\/10.1111\/1759-7714.13745.","journal-title":"Thoracic cancer"},{"key":"891_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gene.2018.11.021","volume":"688","author":"H Lin","year":"2019","unstructured":"Lin H, Lin T, Lin J, Yang M, Shen Z, Liu H, Zou Z, Zheng Z. Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19. Gene. 2019;688:93\u20137. https:\/\/doi.org\/10.1016\/j.gene.2018.11.021.","journal-title":"Gene"},{"key":"891_CR15","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.3892\/etm.2018.6015","volume":"15","author":"X Tang","year":"2018","unstructured":"Tang X, Zeng X, Huang Y, Chen S, Lin F, Yang G, Yang N. miR-423-5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer. Exp Ther Med. 2018;15:4723\u201330. https:\/\/doi.org\/10.3892\/etm.2018.6015.","journal-title":"Exp Ther Med"},{"key":"891_CR16","first-page":"2941","volume":"12","author":"P Zhao","year":"2019","unstructured":"Zhao P, Sun S, Zhai Y, Tian Q, Zhou T, Li J. miR-423-5p inhibits the proliferation and metastasis of glioblastoma cells by targeting phospholipase C beta 1. Int J Clin Exp Pathol. 2019;12:2941\u201350.","journal-title":"Int J Clin Exp Pathol"},{"key":"891_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12958-020-00585-0","volume":"18","author":"S Xie","year":"2020","unstructured":"Xie S, Zhang Q, Zhao J, Hao J, Fu J, Li Y. MiR-423-5p may regulate ovarian response to ovulation induction via CSF1. Reprod Biol Endocrinol. 2020;18:26\u201326. https:\/\/doi.org\/10.1186\/s12958-020-00585-0.","journal-title":"Reprod Biol Endocrinol"},{"key":"891_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Revised,","year":"2003","unstructured":"Revised,. consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2003;81:19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004.","journal-title":"Fertil Steril"},{"key":"891_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1159\/000491894","volume":"48","author":"X Fu","year":"2018","unstructured":"Fu X, He Y, Wang X, Peng D, Chen X, Li X, Wan Q. MicroRNA-16 Promotes Ovarian Granulosa Cell Proliferation and Suppresses Apoptosis Through Targeting PDCD4 in Polycystic Ovarian Syndrome. Cell Physiol Biochem. 2018;48:670\u201382. https:\/\/doi.org\/10.1159\/000491894.","journal-title":"Cell Physiol Biochem"},{"key":"891_CR20","doi-asserted-by":"publisher","first-page":"e14219","DOI":"10.14814\/phy2.14219","volume":"7","author":"Y Song","year":"2019","unstructured":"Song Y, Ye W, Ye H, Xie T, Shen W, Zhou L. Serum testosterone acts as a prognostic indicator in polycystic ovary syndrome-associated kidney injury. Physiol Rep. 2019;7:e14219\u2013e14219. https:\/\/doi.org\/10.14814\/phy2.14219.","journal-title":"Physiol Rep"},{"key":"891_CR21","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1210\/jc.2004-0643","volume":"89","author":"GA Maciel","year":"2004","unstructured":"Maciel GA, Baracat EC, Benda JA, Markham SM, Hensinger K, Chang RJ, Erickson GF. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:5321\u20137. https:\/\/doi.org\/10.1210\/jc.2004-0643.","journal-title":"J Clin Endocrinol Metab"},{"key":"891_CR22","doi-asserted-by":"publisher","first-page":"15414","DOI":"10.18632\/aging.103602","volume":"12","author":"X Huang","year":"2020","unstructured":"Huang X, Wu B, Chen M, Hong L, Kong P, Wei Z, Teng X. Depletion of exosomal circLDLR in follicle fluid derepresses miR-1294 function and inhibits estradiol production via CYP19A1 in polycystic ovary syndrome. Aging (Albany NY). 2020;12:15414\u201335. https:\/\/doi.org\/10.18632\/aging.103602.","journal-title":"Aging (Albany NY)"},{"key":"891_CR23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00404-020-05495-5","volume":"301","author":"C Zhao","year":"2020","unstructured":"Zhao C, Zhou Y, Shen X, Gong M, Lu Y, Fang C, Chen J, Ju R. Circular RNA expression profiling in the fetal side of placenta from maternal polycystic ovary syndrome and circ_0023942 inhibits the proliferation of human ovarian granulosa cell. Arch Gynecol Obstet. 2020;301:963\u201371. https:\/\/doi.org\/10.1007\/s00404-020-05495-5.","journal-title":"Arch Gynecol Obstet"},{"key":"891_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144591","volume":"744","author":"C Jia","year":"2020","unstructured":"Jia C, Wang S, Yin C, Liu L, Zhou L, Ma Y. Loss of hsa_circ_0118530 inhibits human granulosa-like tumor cell line KGN cell injury by sponging miR-136. Gene. 2020;744: 144591. https:\/\/doi.org\/10.1016\/j.gene.2020.144591.","journal-title":"Gene"},{"issue":"24","key":"891_CR25","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.3390\/ijms20246249","volume":"20","author":"M Correia de Sousa","year":"2019","unstructured":"Correia de Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C, Foti M. Deciphering miRNAs\u2019 Action through miRNA Editing. Int J Mol Sci. 2019;20(24):6249. https:\/\/doi.org\/10.3390\/ijms20246249.","journal-title":"Int J Mol Sci"},{"key":"891_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3892\/mmr.2019.10253","volume":"20","author":"Y Hou","year":"2019","unstructured":"Hou Y, Wang Y, Xu S, Qi G, Wu X. Bioinformatics identification of microRNAs involved in polycystic ovary syndrome based on microarray data. Mol Med Rep. 2019;20:281\u201391. https:\/\/doi.org\/10.3892\/mmr.2019.10253.","journal-title":"Mol Med Rep"},{"key":"891_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.7754\/clin.lab.2015.150122","volume":"61","author":"L Jiang","year":"2015","unstructured":"Jiang L, Li W, Wu M, Cao S. Ciculating miRNA-21 as a Biomarker Predicts Polycystic Ovary Syndrome (PCOS) in Patients. Clin Lab. 2015;61:1009\u201315. https:\/\/doi.org\/10.7754\/clin.lab.2015.150122.","journal-title":"Clin Lab"},{"key":"891_CR28","doi-asserted-by":"publisher","first-page":"16306","DOI":"10.1038\/s41598-019-52856-5","volume":"9","author":"AE Butler","year":"2019","unstructured":"Butler AE, Ramachandran V, Hayat S, Dargham SR, Cunningham TK, Benurwar M, Sathyapalan T, Najafi-Shoushtari SH, Atkin SL. Expression of microRNA in follicular fluid in women with and without PCOS. Sci Rep. 2019;9:16306. https:\/\/doi.org\/10.1038\/s41598-019-52856-5.","journal-title":"Sci Rep"},{"key":"891_CR29","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.26355\/eurrev_201903_17222","volume":"23","author":"YL Teng","year":"2019","unstructured":"Teng YL, Lin SY, Yang HY, Meng LH, Yu R, Zeng LC. Effect of microRNA-409 on the pathogenesis of polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2019;23:1874\u201381. https:\/\/doi.org\/10.26355\/eurrev_201903_17222.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"891_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10815-018-1335-x","volume":"36","author":"Y Geng","year":"2019","unstructured":"Geng Y, Sui C, Xun Y, Lai Q, Jin L. MiRNA-99a can regulate proliferation and apoptosis of human granulosa cells via targeting IGF-1R in polycystic ovary syndrome. J Assist Reprod Genet. 2019;36:211\u201321. https:\/\/doi.org\/10.1007\/s10815-018-1335-x.","journal-title":"J Assist Reprod Genet"},{"key":"891_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.omtn.2020.02.007","volume":"20","author":"G Liu","year":"2020","unstructured":"Liu G, Liu S, Xing G, Wang F. lncRNA PVT1\/MicroRNA-17-5p\/PTEN Axis Regulates Secretion of E2 and P4, Proliferation, and Apoptosis of Ovarian Granulosa Cells in PCOS. Mol Ther Nucleic Acids. 2020;20:205\u201316. https:\/\/doi.org\/10.1016\/j.omtn.2020.02.007.","journal-title":"Mol Ther Nucleic Acids"},{"key":"891_CR32","doi-asserted-by":"publisher","first-page":"e621","DOI":"10.1002\/mgg3.621","volume":"7","author":"A Nishikawa","year":"2019","unstructured":"Nishikawa A, Iida A, Hayashi S, Okubo M, Oya Y, Yamanaka G, Takahashi I, Nonaka I, Noguchi S, Nishino I. Three novel MTM1 pathogenic variants identified in Japanese patients with X-linked myotubular myopathy. Mol Genet Genomic Med. 2019;7:e621\u2013e621. https:\/\/doi.org\/10.1002\/mgg3.621.","journal-title":"Mol Genet Genomic Med"},{"key":"891_CR33","doi-asserted-by":"publisher","first-page":"15060","DOI":"10.1073\/pnas.212498399","volume":"99","author":"A Buj-Bello","year":"2002","unstructured":"Buj-Bello A, Laugel V, Messaddeq N, Zahreddine H, Laporte J, Pellissier J-F, Mandel J-L. The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci USA. 2002;99:15060\u20135. https:\/\/doi.org\/10.1073\/pnas.212498399.","journal-title":"Proc Natl Acad Sci USA"},{"key":"891_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tibs.2005.11.013","volume":"31","author":"RH Michell","year":"2006","unstructured":"Michell RH, Heath VL, Lemmon MA, Dove SK. Phosphatidylinositol 3,5-bisphosphate: metabolism and cellular functions. Trends Biochem Sci. 2006;31:52\u201363. https:\/\/doi.org\/10.1016\/j.tibs.2005.11.013.","journal-title":"Trends Biochem Sci"},{"key":"891_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1006\/mcbr.2000.0202","volume":"3","author":"JM Backer","year":"2000","unstructured":"Backer JM. Phosphoinositide 3-kinases and the regulation of vesicular trafficking. Molecular cell biology research communications\u202f: MCBRC. 2000;3:193\u2013204. https:\/\/doi.org\/10.1006\/mcbr.2000.0202.","journal-title":"Molecular cell biology research communications : MCBRC"},{"key":"891_CR36","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/j.1600-0854.2007.00586.x","volume":"8","author":"C Cao","year":"2007","unstructured":"Cao C, Laporte J, Backer JM, Wandinger-Ness A, Stein MP. Myotubularin lipid phosphatase binds the hVPS15\/hVPS34 lipid kinase complex on endosomes. Traffic (Copenhagen, Denmark). 2007;8:1052\u201367. https:\/\/doi.org\/10.1111\/j.1600-0854.2007.00586.x.","journal-title":"Traffic (Copenhagen, Denmark)"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-00891-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-022-00891-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-00891-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T07:05:29Z","timestamp":1645081529000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-022-00891-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1186\/s12958-022-00891-9","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"21 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from patients with approval by the Institutional Review Board in The Hospital of Bayannaoer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no financial conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}